View this email in your browser

The monthly European Industrial Pharmacists newsletter • January 2018

Technology & Production
The first digital pill soon on the market

The era of digital medicines is here: the first “digital pill” was approved by the Food and Drug Administration on November 13th, 2017 and other technologies are under development in the research labs.

Read more...
 
Politics & Business
Updates on the Brexit procedure

EMA published new Questions & Answers to help the pharmaceutical companies updating their authorisation dossiers in time to be ready to meet the new requirements that shall come into force with the Brexit.

Read more...
 
Regulatory
The draft of the new Annex 1 is open to consultation

The new Annex 1 of the GMPs on the “Manufacture of Sterile Medicinal Products” has been published by the European Commission and is currently open to consultation until 20 March 2018. The structure of the document has been revised compared to the previous version.

Read more...
 
Focus on EU’s Countries
New measures on the entry of new medicines in the Greek market

The Greek pharmaceutical sector is under pressure due to the Government’s new policy that delays the launch of new innovative medicines for up to four years and adds an extra rebate of 25% for two years. Many companies are considering to stop the supply of innovative drugs.

Read more...
 
News from EIPG
EIPG's webinar on Paediatrics and EMA meeting with Interested parties

Read more...
 

© 2020 Tecniche Nuove Spa. All rights reserved
Tecniche Nuove Spa – Via Eritrea, 21 – 20157 Milano – Italy
VAT 00753480151
Your e-mail address is used only and exclusively for sending the messages of this service.
Owner of the data treatment is the national Association member of EIPG, sender of this newsletter. Please refer to your Association internet site to update or modify your data treatment consent or wish to be cancelled from this newsletter mailing list.
Forward this newsletter to a friend
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -